arrow_back Trending Legislation
Share share

Free Access to HIV Prevention: PrEP Access and Coverage Act of 2026

This act ensures free access to HIV prevention medication (PrEP) by eliminating out-of-pocket costs for most private and public insurance plans. It also protects individuals from insurance discrimination and funds public education to reduce HIV transmission.
Key points
Eliminates copays and deductibles for HIV prevention drugs, lab tests, and clinical visits.
Prohibits insurance companies from requiring prior authorization for PrEP medications.
Prevents life and disability insurers from denying coverage or raising rates based on PrEP use.
Ensures patient privacy for those using prevention services under a family insurance plan.
Provides grants to support access for uninsured and underinsured individuals.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
PrEP Access and Coverage Act of 2026
Print number: HR 7853
Sponsor: Rep. Takano, Mark [D-CA-39]
Process start date: 2026-03-05
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Free Access to HIV Prevention: PrEP Access and Coverage Act of 2026

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 7853.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2026-03-05.

What are the main provisions?

Key points include:

  • Eliminates copays and deductibles for HIV prevention drugs, lab tests, and clinical visits.
  • Prohibits insurance companies from requiring prior authorization for PrEP medications.
  • Prevents life and disability insurers from denying coverage or raising rates based on PrEP use.
  • Ensures patient privacy for those using prevention services under a family insurance plan.
  • Provides grants to support access for uninsured and underinsured individuals.

What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Takano, Mark [D-CA-39].

What is the latest detailed status?

The latest detailed status is: Introduced in House

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-03-25.

Analysis and Potential Impact of HR 7853

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health